Schwab's Dividend ETF Keeps Hitting Records. I'd Still Buy It Now.

The Schwab U.S. Dividend Equity ETF closed at $35.78 on Oct. 30, its 28th record close of 2026, and has returned about 34% including dividends this year, versus about 11% for the S&P 500. Its current yield is around 2.9%, down from about 3.8% at the end of 2025, while recent distributions are only about 2% higher year over year. The article’s author still views the fund as worth buying, citing its lower reported P/E than a broad-market ETF, but cautions investors not to expect another year like 2026.

Analysis

The key risk is not the record close; it is that price appreciation has outpaced the income stream while distribution growth is decelerating. That weakens SCHD’s near-term income proposition and leaves less support for further multiple expansion. Its reported P/E discount to the broad market may be real, but could also reflect a different sector and factor mix rather than mispricing; confirm current holdings, concentration, and forward earnings before treating the gap as protection.

Over days to weeks, momentum and dividend-oriented flows could persist, so a record alone is not a short signal. Over 1–3 months, the test is whether constituent earnings and declared dividends sustain or reaccelerate payouts; another period of weak distribution growth could pressure the fund’s relative performance. Over 6–18 months, the larger risk is a reversal in value/income leadership—particularly if real yields rise or growth stocks regain leadership. The 2021 analogy is a drawdown scenario, not a forecast: outcomes depend on today’s holdings, starting valuations, and payout growth. A thesis of continued income resilience is falsified by broad constituent dividend cuts or a sustained decline in distributions; the relative-value case weakens if SCHD’s valuation discount closes without corresponding earnings or payout improvement.

Key Decisions for Investors

• Do not chase SCHD solely on the record or extrapolate its recent total return. For strategic income exposure, scale entries over time rather than committing all at once; reassess if distribution growth continues to lag.
• Treat SCHD versus a broad-market ETF such as SPY as a relative-value watch, not an automatic pair trade. Consider reducing the relative-value thesis if the valuation gap narrows while constituent earnings and dividends fail to improve; verify comparable forward metrics and holdings first.
• Track quarterly distributions, constituent dividend announcements, and changes in portfolio concentration. A payout decline or a marked increase in cuts would invalidate the income-resilience premise; rising real yields alongside sustained SCHD underperformance would strengthen the case to wait for a better entry.